[Broncholytic aerosols; with special attention to juvenile patients].
D000293:Adolescent; D000336:Aerosols; D000367:Age Factors; D000402:Airway Obstruction / Q000188:drug therapy; D000403:Airway Resistance / Q000187:drug effects; D000420:Albuterol / Q000627:therapeutic use; D001249:Asthma / Q000188:drug therapy*; D001827:Body Height; D002648:Child; D006594:Hexoprenaline / Q000627:therapeutic use*; D006801:Humans; D007545:Isoproterenol / Q000627:therapeutic use; D009921:Metaproterenol / Q000627:therapeutic use; D010627:Phenethylamines / Q000627:therapeutic use*; D010993:Plethysmography, Whole Body; D011674:Pulse / Q000187:drug effects; D014797:Vital Capacity
D000336:Aerosols; D010627:Phenethylamines; D009921:Metaproterenol; D006594:Hexoprenaline; D007545:Isoproterenol; D000420:Albuterol
Broncholytische Aerosole Unter besonderer Berücksichtigung des Kindesalters.